Udayavni Special

Covaxin is effective against UK variant of coronavirus: ICMR study

Airlifted COVID vaccines to 9 countries, will gradually supply to WHO’s COVAX facility informs India at UN

Seven more states to administer Covaxin from next week: Health Ministry

Ph 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

COVID-19 vaccines sent by India reach Bhutan and Maldives

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

‘Do not take antidote if…’: Bharat Biotech says in fact sheet on Covaxin

62% of designated beneficiaries vaccinated on day one in Karnataka

Bharat Biotech to pay compensation if Covaxin causes side effects

More than 240 centres ready for vaccination drive in K’taka

Efficacy of vaccine: Recipients don’t have the option to choose one vaccine over the other

Experts’ group slam critics of India’s COVID-19 vaccines approval process

Two districts of K’taka receive over two lakh doses of Covishield

Covaxin shipped to 11 cities in India, says Bharat Biotech

Covid vaccine recipients will not get to choose from 2 options for now: Centre

Stop Covaxin trial in Bhopal, NGOs working for 1984 gas tragedy victims tell PM Modi

Man dies days after participating in Covaxin Covid-19 vaccine trial in Bhopal

Bharat Biotech achieved a milestone in indigenous vaccinology: Min Sudhakar

3 more test positive for COVID-19 UK strain in K’taka: Min Sudhakar

COVID-19 vaccine to cost $3-4 to govt, $6-8 in pvt mkt says Serum Institute

Covishield vs Covaxin: How do they stack up against each other?

Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of Covaxin

Covaxin can work against mutated Covid-19 virus, says Bharat Biotech Chairman

Bharat Biotech, Ocugen to co-develop Covaxin for US market

Bharat Biotech’s intranasal COVID-19 vaccine to enter phase 1 trials next month

Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin

Covaxin a 2-dose anti-coronavirus vaccine, Anil Vij got only 1st dose: Union health ministry

Covaxin Phase-3 trials begins in Karnataka

Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

Haryana’s Health Minister Anil Vij to Be Administered Trial Dose of Covid Vaccine Covaxin

Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials

Bharat Biotech planning to launch Covid-19 vaccine ‘Covaxin’ in second quarter of 2021

COVID-19: Third phase human trial of COVAXIN to commence soon

Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India

Latest Additions

Two sanitation workers die while cleaning sewer in Kalaburagi

Scientists find different variant of SARS-CoV-2 in South India, step up research to ascertain prevalence

India needs bold, multifaceted policy response to secure robust economic recovery: IMF

36-year old woman from J&K’s Poonch crosses over to PoK, returned by Pakistan

Suratkal: Three arrested in youth stabbing case

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.